The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Ruddy Marcella K. | Director | Grant(A) | 17K | — | $0 |
| Jun 9, 2026 | Renaud Ronald C JR | Director | Grant(A) | 17K | — | $0 |
| Jun 9, 2026 | Fleming Harold Edward | Director | Grant(A) | 17K | — | $0 |
| Jun 9, 2026 | Beckman Daniella | Director | Grant(A) | 17K | — | $0 |
| Jun 9, 2026 | Ratcliffe Liam | Director | Grant(A) | 17K | — | $0 |
| Jun 9, 2026 | Chimovits Erez | Director | Grant(A) | 17K | — | $0 |
| Mar 16, 2026 | Houghton Adam | Chief Business Officer | Sell(S) | 699 | $9.29 | $6K |
| Mar 16, 2026 | Ambrose Allison | General Counsel | Sell(S) | 475 | $9.29 | $4K |
| Mar 16, 2026 | Sutherland Everett Rand | Chief Executive Officer, Director | Sell(S) | 2K | $9.29 | $19K |
| Mar 16, 2026 | Deykin Aaron | Chief Medical Officer | Sell(S) | 894 | $9.29 | $8K |
| Mar 16, 2026 | Gray Michael | CFO and COO | Sell(S) | 852 | $9.29 | $8K |
| Jan 2, 2026 | Sutherland Everett Rand | Chief Executive Officer, Director | Grant(A) | 75K | — | $0 |
| Jan 2, 2026 | Sutherland Everett Rand | Chief Executive Officer, Director | Grant(A) | 225K | — | $0 |
| Jan 2, 2026 | Houghton Adam | Chief Business Officer | Grant(A) | 25K | — | $0 |
| Jan 2, 2026 | Houghton Adam | Chief Business Officer | Grant(A) | 75K | — | $0 |
| Jan 2, 2026 | Ambrose Allison | General Counsel | Grant(A) | 17K | — | $0 |
| Jan 2, 2026 | Ambrose Allison | General Counsel | Grant(A) | 51K | — | $0 |
| Jan 2, 2026 | Deykin Aaron | Chief Medical Officer | Grant(A) | 32K | — | $0 |
| Jan 2, 2026 | Deykin Aaron | Chief Medical Officer | Grant(A) | 96K | — | $0 |
| Jan 2, 2026 | Gray Michael | CFO and COO | Grant(A) | 31K | — | $0 |
| Jan 2, 2026 | Gray Michael | CFO and COO | Grant(A) | 92K | — | $0 |
| Jun 10, 2025 | Ratcliffe Liam | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2025 | Chimovits Erez | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2025 | Fleming Harold Edward | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2025 | Renaud Ronald C JR | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2025 | Beckman Daniella | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2025 | Ruddy Marcella K. | Director | Grant(A) | 17K | — | $0 |
| Feb 6, 2025 | Ambrose Allison | General Counsel | Grant(A) | 25K | — | $0 |
| Feb 6, 2025 | Deykin Aaron | Chief Medical Officer | Grant(A) | 165K | — | $0 |
| Feb 6, 2025 | Houghton Adam | Chief Business Officer | Grant(A) | 140K | — | $0 |
| Feb 6, 2025 | Gray Michael | CFO and COO | Grant(A) | 195K | — | $0 |
| Feb 6, 2025 | Sutherland Everett Rand | Chief Executive Officer, Director | Grant(A) | 500K | — | $0 |
| Dec 16, 2024 | Ambrose Allison | General Counsel | Grant(A) | 100K | — | $0 |
| Oct 15, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 2.9M | — | — |
| Oct 15, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 165K | $17.00 | $2.8M |
| Oct 15, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 722K | — | — |
| Oct 15, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 660K | $17.00 | $11.2M |
| Oct 15, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 790K | — | — |
| Oct 15, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 197K | — | — |
| Oct 15, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 2.1M | — | — |
| Oct 15, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 525K | — | — |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Conversion(C) | 722K | — | — |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Buy(P) | 165K | $17.00 | $2.8M |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Conversion(C) | 2.9M | — | — |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Buy(P) | 660K | $17.00 | $11.2M |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Conversion(C) | 197K | — | — |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Conversion(C) | 2.1M | — | — |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Conversion(C) | 525K | — | — |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Conversion(C) | 790K | — | — |
| Oct 15, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 895K | — | — |
| Oct 15, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 853K | — | $0 |
| Oct 15, 2024 | Access Industries Holdings LLC | 10% Owner | Buy(P) | 1.2M | $17.00 | $20.0M |
| Oct 15, 2024 | Access Industries Holdings LLC | 10% Owner | Conversion(C) | 3.1M | — | — |
| Oct 15, 2024 | Access Industries Holdings LLC | 10% Owner | Conversion(C) | 1.2M | — | — |
| Oct 15, 2024 | Access Industries Holdings LLC | 10% Owner | Conversion(C) | 3.1M | — | — |
| Oct 15, 2024 | Access Industries Holdings LLC | 10% Owner | Conversion(C) | 1.2M | — | — |
| Oct 10, 2024 | Ratcliffe Liam | Director | Grant(A) | 17K | — | $0 |
| Oct 10, 2024 | Fleming Harold Edward | Director | Grant(A) | 17K | — | $0 |
| Oct 10, 2024 | Ruddy Marcella K. | Director | Grant(A) | 17K | — | $0 |
| Oct 10, 2024 | Chimovits Erez | Director | Grant(A) | 17K | — | $0 |
| Oct 10, 2024 | Beckman Daniella | Director | Grant(A) | 35K | — | $0 |
| Oct 10, 2024 | Renaud Ronald C JR | Director | Grant(A) | 17K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).